Back to Search
Start Over
IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN
- Source :
- Hematological Oncology. 35:117-119
- Publication Year :
- 2017
- Publisher :
- Wiley, 2017.
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Follicular lymphoma
chemistry.chemical_element
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Obinutuzumab
Internal medicine
medicine
030212 general & internal medicine
Study analysis
Gallium
business.industry
Hematology
General Medicine
medicine.disease
Chemotherapy regimen
chemistry
030220 oncology & carcinogenesis
Immunology
Rituximab
business
medicine.drug
Subjects
Details
- ISSN :
- 02780232
- Volume :
- 35
- Database :
- OpenAIRE
- Journal :
- Hematological Oncology
- Accession number :
- edsair.doi...........ac259b1f215465da91ca649b9e475ce4